Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDA1 domain containing 1 pseudogene 4 (SDAD1P4) is classified as a pseudogene, meaning it is a non-protein-coding genomic sequence that is similar to the functional SDA1 domain containing 1 gene (SDAD1) but lacks the ability to produce a functional protein due to inactivating mutations[1][3]. While some pseudogenes can regulate other genes via RNA-mediated mechanisms or interact with microRNAs, there is no reported functional or disease-specific role for SDAD1P4. It is not considered a receptor, enzyme, transporter, or other typical pharmacological target, and there are no known drugs, mechanisms of action, biomarkers, or safety concerns associated with this gene[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SDA1 domain containing 1 pseudogene 4 (SDAD1P4).